Browsing by Author "Mahave, M."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemConvalescent plasma in COVID-19. Mortality-safety first results of the prospective multicenter FALP 001-2020 trial(2020) Gazitúa, R.; Briones, J. L.; Selman, C.; Villarroel Espíndola, F.; Aguirre, A.; González Steigmaier, R.; Cereceda, K.; Mahave, M.; Rubio, B.; Ferrer Rosende, P.; Sapunar, J.; Marsiglia, H.; Morales, R.; Yarad, F.; Balcells Marty, María Elvira; Rojas, Luis; Nervi Nattero, Bruno; Nien, J. K.; Garate, J.; Prieto, C.; Palma, S.; Escobar, C.; Bascuñan, J.; Muñoz, R.; Pinto, M.; Cardemil, D.; Navarrete, M.; Reyes, S.; Espinosa, V.; Yáñez, N.; Caglevic, C.
- ItemHepatocellular carcinoma in identical twins in Chile: case report(2016) Caglevic, C.; Silva, S.; Mahave, M.; Torres Montes, Paula Javiera; Rolfo, C.; Gallardo, J.; Carrasco, P.Liver cancer is the second leading cause of cancer death worldwide, with hepatocellular carcinoma (HCC) being the most common type of primary malignant liver tumour, with a typically poor prognosis, growing incidence and a well-documented relationship with chronic inflammation factors of the liver tissue. Despite the fact that family medical history has been identified as a risk factor for the development of HCC, its significance in terms of etiopathogenesis and prognosis is not well documented. With a view to contributing to this discussion, we will report the clinical case of two identical twins with HCC, both diagnosed within a short period of time, by providing relevant clinical data, and relating this to other medical literature reports that could contribute to a deeper understanding of this illness.